Premium
Erratum: Immunoreactivities of polyclonal and monoclonal anti‐T and anti‐Tn antibodies with human carcinoma cells, grown in vivo and in a xenograft model. Int. J. Cancer , 72, 119‐127 (1997)
Author(s) -
Avichezer Dody,
Springer George F.,
Schechter Bilha,
Ar Ruth
Publication year - 1997
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/(sici)1097-0215(19970904)72:5<918::aid-ijc34>3.0.co;2-1
Subject(s) - polyclonal antibodies , monoclonal antibody , in vivo , monoclonal , in vitro , microbiology and biotechnology , antibody , carcinoma , cancer , biology , medicine , pathology , immunology , biochemistry , genetics
Avichezer, Dody, Springer, Georg F., Schechter, Bilha, and Arnon, Ruth, Immunoreactivities of polyclonal and monoclonal anti‐T and anti‐Tn antibodies with human carcinoma cells, grown in vitro and in a xenograft model. Int. J. Cancer, 72, 119‐127 (1997). The following information was published incorrectly in the article by Avichezer et al. 1. On page 120, line 9, left‐hand column: monoclonal anti‐Tn antibody should read Ca 3783, not 3782, the latter has anti‐T specificity. 2. On page 123, Table II, footnote 2 should read as follows: The data in brackets show the percent inhibition, which is significant compared to the respective control cells, tested without carbohydrate and represent percent inhibition, observed in MFI, resulting from the presence of the carbohydrate. 3. The lettering in all Figures should appear in lower case italics ( a,b,c,d ) as in the text and legends.